Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 6Phase 1/2 5Phase 3 4Phase 4 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 25Unknown 16Withdrawn 3Terminated 3Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Polycystic Ovary Syndrome 1Obesity 1Infertility 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Metformin × Clear all
NCT06742710 2025-05-29

LITOP

Peking University Third Hospital

Phase 4 Recruiting
890 enrolled
Other

Infertility, Obesity, Polycystic Ovary Syndrome

NCT06215976 2024-08-20

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

Cairo University

Phase 4 Recruiting
78 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡